Arbuthnot Banking Group’s strategic positioning creates enormous value (LON:ARBB)
Arbuthnot Banking Group plc (LON:ARBB) sees strong profit growth in 2023 as strategic positioning pays off. Analyst Mark Thomas shares key findings.
Arbuthnot Banking Group plc (LON:ARBB) sees strong profit growth in 2023 as strategic positioning pays off. Analyst Mark Thomas shares key findings.
The UK’s blue-chip share index cruised to record highs on Tuesday, helped by a weaker pound and positive corporate updates, while investors focussed on earnings from U.S. tech giants this
Oil prices gained on Tuesday after stronger economic data out of Europe, as investors also weighed the potential fallout from any fresh U.S. sanctions on Iran’s oil exports with tensions
Device Authority’s KeyScaler-as-a-Service solution has been named the winner of IoThinkTank’s IoT Security Product of the Year in its Best of 2023 Awards. As the premier hub for recognizing excellence in
Cerillion announced the successful migration of Telesur’s fixed line customers onto its convergent BSS/OSS platform. This marks the full completion of this large digital transformation project, following the earlier migration of
The Canadian energy company operating in T&T, Touchstone Exploration, in an operational update, said the Cascadura-3ST1 well has been cased and production testing is scheduled to commence in the third
Union Jack Oil plc (LON:UJO, OTCQB: UJOGF), a UK and USA focused onshore hydrocarbon production, development, exploration and investment company, has announced that a new Corporate Presentation is now available:
Boku Inc, a leading provider of global mobile payment solutions, has announced that it has posted its notice of Annual General Meeting to stockholders. Copies of the notice of AGM
Baron Oil Plc (LON:BOIL) has provided a further update regarding the changes to the Company’s board of Directors and executive positions. Summary of changes to the Board John Wakefield has stepped
N4 Pharma Plc (LON:N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, has announced its audited results for the year ended 31 December 2023.